Table 1. Categorical density scores for CD3+, CD8+, CD4+, and PD-1+ TILs.
| Primary | Recurrence | |||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | |
| CD3 | ||||||||
| Tumor | - | 9 (69.2%) | 4 (30.8%) | - | - | 8 (61.5%) | 4 (30.8%) | 1 (7.7%) |
| Perivascular | 2 (15.4%) | 8 (61.5%) | 2 (15.4%) | 1 (7.7%) | 2 (15.4%) | 7 (53.8%) | 4 (30.8%) | - |
| Bleeds | 7 (53.8%) | 5 (38.5%) | - | 1 (7.7%) | 6 (46.2%) | 4 (30.8%) | - | 3 (23.1%) |
| CD8 | ||||||||
| Tumor | - | 9 (69.2%) | 4 (30.8%) | - | - | 8 (61.5%) | 4 (30.8%) | 1 (7.7%) |
| Perivascular | 5 (38.5%) | 6 (46.2%) | 2 (15.4%) | - | 2 (15.4%) | 8 (61.5%) | 3 (23.1%) | - |
| Bleeds | 8 (61.5%) | 4 (30.8%) | - | 1 (7.7%) | 5 (38.5%) | 5 (38.5%) | 1 (7.7%) | 2 (15.4%) |
| CD4 | ||||||||
| Tumor | 9 (69.2%) | 3 (23.1%) | 1 (7.7%) | - | 3 (23.1%) | 9 (69.2%) | 1 (7.7%) | - |
| Perivascular | 5 (38.5%) | 5 (38.5%) | 2 (15.4%) | 1 (7.7%) | 3 (23.1%) | 9 (69.2%) | 1 (7.7%) | - |
| Bleeds | 9 (69.2%) | 3 (23.1%) | - | 1 (7.7%) | 6 (46.2%) | 6 (46.2%) | 1 (7.7%) | - |
| PD-1 | ||||||||
| Tumor | 9 (75.0%) | 3 (25.0%) | - | - | 6 (50.0%) | 4 (41.6%) | 1 (8.3%) | - |
| Perivascular | 10 (83.3%) | 2 (16.7%) | - | - | 9 (75.0%) | 3 (25.0%) | - | - |
| Bleeds | 12 (100.0%) | - | - | - | 10 (83.3%) | 2 (16.7%) | - | - |